Christophe Le Tourneau, M.D., Ph.D., is a senior medical oncologist at the Institut Curie and Professor of Medicine at Paris-Saclay University. He is heading the Department of Drug Development and Innovation (D3i), as well as the Head and Neck Clinic. He is leading the early-phase clinical trials program of the Institut Curie. Christophe was certified in Medical Oncology in 2005 and earned his Ph.D. in Clinical Epidemiology in 2007. He engaged in a two-year clinical research fellowship at Princess Margaret Hospital in Toronto, Canada, in the drug development program. His main interests are precision medicine, phase I clinical trials with special attention to the methodology to conduct these trials, and head and neck oncology. Christophe is leading several precision medicine projects at the national and international levels. He has published over 180 peer-reviewed papers in international journals.